Skip to main content
. 2022 Aug 25;36(10):2351–2367. doi: 10.1038/s41375-022-01666-2

Fig. 5. Dual CAR targeting of CD33 and CD123.

Fig. 5

The rationale of CD123/CD33 dual targeting trans-signaling strategy is to induce a full cell activation against only CD123/CD33+ leukemic cells while reducing cell stimulation against CD33+ HSPCs and CD123+ endothelial cells [144].